Medac Pharma, Inc.

10 articles about Medac Pharma, Inc.

• Medac Pharma Announces the Patent Trial and Appeal Board Upheld Patents on Rasuvo (Single Dose Auto-Injection of Methotrexate)

  2/9/2018

  This ruling ends the challenge brought by Koios Pharmaceuticals LLC.

• Medac Pharma, Inc. Appoints Industry Veteran As Vice President Of Sales In The U.S.

  12/13/2016

• Medac Pharma, Inc. Announces Settlement Of Patent Infringement Lawsuits

  4/16/2015

• Medac Pharma, Inc. Brings Motion To Preliminarily Prohibit Antares Pharma, Inc. Sales Of Otrexup To New Patients

  11/24/2014

• Medac Pharma, Inc.'s Rasuvo (methotrexate) Injection Now Available For Patients With Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis

  10/6/2014

• Medac Pharma, Inc. Wins FDA Approval Of Rasuvo Injection For Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis

  7/14/2014

• Medac Pharma, Inc. Announces Successful FDA Inspection Of Its Exclusive Methotrexate Manufacturer

  5/15/2014

• Medac Pharma, Inc. Secures FDA Acceptance Of A New Drug Application (NDA) For Methotrexate-Containing Autopen

  1/27/2014

• Medac Pharma, Inc. Announces Multiple Poster Presentations During the 2013 ACR/ARHP Annual Meeting

  10/21/2013

• Newly Established Medac Pharma, Inc. Appoints Industry Veteran Terri Shoemaker as President and CEO

  10/16/2013